Title:
MEDICINAL COMPOSITION FOR TREATING FIBROSIS
Document Type and Number:
WIPO Patent Application WO/2017/141942
Kind Code:
A1
Abstract:
The present disclosure provides a medicinal composition for treating fibrosis, said medicinal composition comprising a reovirus as an active ingredient.
Inventors:
SAKURAI FUMINORI (JP)
MIZUGUCHI HIROYUKI (JP)
MIZUGUCHI HIROYUKI (JP)
Application Number:
PCT/JP2017/005443
Publication Date:
August 24, 2017
Filing Date:
February 15, 2017
Export Citation:
Assignee:
UNIV OSAKA (JP)
International Classes:
A61K35/765; A61P1/00; A61P1/04; A61P1/16; A61P7/00; A61P9/00; A61P9/10; A61P11/00; A61P13/12; A61P29/00; A61P43/00; C12N7/00
Domestic Patent References:
| WO2008044627A1 | 2008-04-17 |
Foreign References:
| JP2014196329A | 2014-10-16 | |||
| JP2004502741A | 2004-01-29 | |||
| JPH07322877A | 1995-12-12 |
Other References:
TADATAKA KAMINADE ET AL.: "Shuyo Yokaisei Virus de aru Reovirus ni yoru Gan Kanren Sen'iga Saibo ni Taisuru Satsusaibo Koka ni Kansuru Kento", PHARMACEUTICAL SOCIETY OF JAPAN 135 NENKAI DVD YOSHISHU, vol. 135, 2015, pages 28U-pm02S, XP009515146
MIYAMOTO, S.D. ET AL.: "Cardiac Cell -specific Apoptotic and Cytokine Responses to Reovirus Infection: Determinants of Myocarditic Phenotype", JOURNAL OF CARDIAC FAILURE, vol. 15, no. 6, August 2009 (2009-08-01), pages 529 - 539, XP055548899
MIYAMOTO, S.D. ET AL.: "Cardiac Cell -specific Apoptotic and Cytokine Responses to Reovirus Infection: Determinants of Myocarditic Phenotype", JOURNAL OF CARDIAC FAILURE, vol. 15, no. 6, August 2009 (2009-08-01), pages 529 - 539, XP055548899
Attorney, Agent or Firm:
SAMEJIMA, Mutsumi et al. (JP)
Download PDF: